{"id":122545,"date":"2026-06-18T14:54:29","date_gmt":"2026-06-18T09:24:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=122545"},"modified":"2026-06-18T14:54:31","modified_gmt":"2026-06-18T09:24:31","slug":"max-healthcare-share-price-surge-citi-buy-june-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/max-healthcare-share-price-surge-citi-buy-june-2026\/","title":{"rendered":"Max Healthcare Share Price Jumps 6% to Lead Nifty 50 on 18 June 2026; Citi Sees 20% EBITDA CAGR to FY30"},"content":{"rendered":"
<\/div>\n

Max Healthcare share price Rs 1,077.75 (+5%, high Rs 1,088\/+6%) on 18 Jun 2026, top Nifty gainer. Citi Buy target Rs 1,240. 20% EBITDA CAGR FY26-30E. New capacity, oncology, better payer mix.<\/em><\/p>\n

Max Healthcare share price surged up to 6% on 18 June 2026, touching a day high of Rs 1,088 and emerging as the top Nifty 50 gainer, after Citi reiterated a Buy rating with a Rs 1,240 target citing an attractive entry point after the stock’s 18% correction and projecting a 20% EBITDA compound annual growth rate from FY26 to FY30. The brokerage highlighted new hospital capacity additions, recovery in the oncology segment and an improving payer mix as the three key drivers behind the EBITDA re-rating thesis, which pushed Max Healthcare share price to its session high before a partial pullback to Rs 1,077.75.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n